This can still be a good stock without another mania
rerating. If signed capacity becomes recurring rent, the mix shifts away from
fit-out and pass-through revenue, and capital recycling improves, the business should look more like contracted AI infrastructure than a speculative build story. The limiting factor is that much of the near-term scarcity narrative is already in the stock, so upside depends more on execution compounding than on multiple expansion alone.